Medical Students For Lymphoma Research is categorized under Medical Research in Denver, CO and active since 2010.
Medical Students For Lymphoma Research was established in 2010, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact Mary Naam at the company’s single location by writing to 2909 East 7th Avenue Parkway, Denver, Colorado CO 80206 or by phoning (267) 971-2250. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Medical Students For Lymphoma Research |
| Contact Person: | Mary Naam |
| Address: | 2909 East 7th Avenue Parkway, Denver, Colorado 80206 |
| Phone Number: | (267) 971-2250 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 541720 |
| Share This Business: |
Medical Students For Lymphoma Research was started in 2010 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Mary Naam for inquiries that concern Medical Students For Lymphoma Research by calling the company number (267) 971-2250, as your correspondence is most welcome. Additionally, the physical location of the single location of Medical Students For Lymphoma Research can be found at the coordinates 39.727446,-104.952691 as well as the street address 2909 East 7th Avenue Parkway in Denver, Colorado 80206.
For its online presence, you may visit Medical Students For Lymphoma Research’s website at and engage with its social media outlets through on Twitter and on Facebook.